Alba Antúnez-Rodríguez

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer

Luis Javier Martínez-González, Victor Sánchez-Conde, Jose María González-Cabezuelo et al. · Biomedicines · 2021 · 25 citations · Full text

Medicine, Molecular Biology, Oncology +17

Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer

Luis Javier Martínez-González, Alba Antúnez-Rodríguez, Fernando Vázquez‐Alonso et al. · The Science of The Total Environment · 2020 · 19 citations

Medicine, Genetics, Oncology +17

Circulating PTGS2, JAG1, GUCY2C and PGF mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer

Cristina Jiménez‐Luna, Encarnación González‐Flores, Raúl Ortíz et al. · Journal of Clinical Medicine · 2021 · 18 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome

Celia Castaño‐Amores, Alba Antúnez-Rodríguez, Ana Pozo-Agundo et al. · Biomedicine & Pharmacotherapy · 2023 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16